Table 3.
Local recurrences: clinical characteristics
| Age (yrs) | Presentation | Tumour type | Size (mm) | Tumour grade | No. of (+) nodes | ER status | NPI Score | Interval (mts) | Radial margin (mmm) | Re-excision | RT | RT bose | Hormone therapy | Chemotherapy | Systemic recurrence | Comment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 52 | Symptomatic | IDC | 15 | 2 | N/A | + | N/A | 49 | 15 | Yes | No | No | No | No | No | See below* |
| 50 | Screening | IDC | 14 | 3 | 1 | − | 5.28 | 39 | 21 | No | Yes | Yes | No | Yes | No | |
| 55 | Symptomatic | IDC | 18 | 3 | 1 | + | 5.36 | 23 | 10 | No | Yes | Yes | Yes | Yes | Yes | |
| 44 | Symptomatic | IDC | 16 | 3 | 2 | + | 5.32 | 15 | 20 | No | Yes | Yes | Yes | Yes | Yes | |
| 53 | Symptomatic | IDC | 24 | 3 | 2 | + | 5.48 | 26 | 13 | No | Yes | Yes | Yes | Yes | No |
*
Patient refused axillary surgery, hence NPI not applicable
IDC, infiltrating ducta carcinoma; ER, oestrogen receptor; (+) positive; (−) negative; N/A not applicable; RT, radiotherapy.